Breathlessness patterns in adults with cancer, COPD, or heart failure using brain fMRI and immersive virtual reality
Official title: Breathlessness Patterns in Patients With Cancer, COPD and Heart Failure: an fMRI Feasibility Study
Run by University Hospital, Geneva · NCT07319039 · Data updated 2026-11-12
This project will try to use brain fMRI combined with immersive virtual reality to identify patterns of persistent breathlessness in adults with COPD, heart failure, or cancer and in healthy volunteers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 16 (estimated) |
| Sponsor | University Hospital, Geneva Academic / other |
| Locations | 1 site (Geneva, Canton of Geneva) |
| Status | Recruiting |
| Started | August 26, 2025 |
| Main results expected | March 1, 2027 |
| Study ends | March 1, 2027 |
| Registry record updated | January 8, 2026 |
| Trial ID | NCT07319039 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) followed by the Geneva University Hospitals outpatient palliative clinic with persistent breathlessness (>3 weeks), NRS breathlessness >2 and <8, and a diagnosis of NYHA III-IV heart failure, COPD with mMRC grade 3–4, or cancer with pulmonary involvement are the intended participants.
✕Probably not a fit
Patients with recent hospitalization for acute cardiac, respiratory, or neurological failure, those with contraindications to fMRI, or those whose breathlessness is outside the study's NRS range (≤2 or ≥8) are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will use cerebral functional MRI together with immersive virtual reality stimuli to record brain activity associated with persistent dyspnea in patients and in healthy control volunteers. The observational feasibility protocol enrolls adults followed at the Geneva University Hospitals outpatient palliative clinic who meet disease-specific breathlessness criteria and healthy volunteers without cardiorespiratory or oncologic disease. During imaging sessions standardized symptom ratings and IVR triggers will be applied to explore central nervous system signaling and potential disease-specific breathlessness patterns. The primary goal is to determine whether distinct, reproducible brain activity patterns can be detected across disease groups to inform future targeted therapies.
Why it matters
Potential benefit: If successful, this could help match breathlessness treatments to disease-specific brain patterns and reduce one-size-fits-all prescribing such as routine opioid use.
How similar studies have gone: Previous fMRI work has mainly studied healthy volunteers or acute breathlessness and immersive VR has been used to reduce MRI anxiety, but applying fMRI plus IVR to chronic breathlessness across cancer, COPD, and heart failure is largely novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Age ≥ 18 years and * Followed by the outpatient palliative care clinic of the Geneva University Hospitals, Switzerland (HUG) and * Breathlessness at rest \> 2 and \< 8 on the NRS (numeric rating scale 0 to 10) and * Persistent breathlessness (persistent dyspnea for \> 3 weeks despite adequate and maximal medication according to the pathology) and * In a stable clinical condition, i.e., without an episode of acute cardiac, respiratory, and/or neurological failure leading to hospitalization in the previous 4 weeks and * Diagnosis of either HF stage NYHA III-IV, or COPD with dyspnea on the modified MRC scale grade 3-4, or oncological disease with primary or secondary pulmonary involvement Inclusion Criteria for Healthy Volunteers (Control Group) * Age ≥ 18 years and * No respiratory symptoms: dyspnea, cough, wheezing and * No known pulmonary, cardiac, or oncological disease and * Smoking status \< 10 pack-years and * No contraindication to fMRI (Appendix 3) and * Ability to lie flat (supine position) and * No diagnosed psychiatric illness (severe depression, severe anxiety, psychosis, other) or antipsychotic treatment deemed a contraindication for fMRI based on physician judgement and * No neurological disorders according to neurological assessment, including diagnosed dementia (frontotemporal dementia, Alzheimer's disease, etc.), brain pathology (tumor, stroke, Parkinson's disease, etc.), or epilepsy and * No claustrophobia, acrophobia, photophobia, severe hearing loss, and/or severe visual deficit and * No contraindication to IVR (migraines, photosensitive epilepsy, vertigo) Exclusion Criteria * Breathlessness at rest ≥ 8 on the NRS (numeric rating scale 0 to 10) * Contraindication to fMRI * Inability to lie flat (supine position) * Diagnosed psychiatric illness (severe depression, severe anxiety, psychosis, other) or antipsychotic treatment deemed a contraindication for fMRI based on physician judgement * Neurological disorders according to neurological assessment, including diagnosed dementia (frontotemporal dementia, Alzheimer's disease, etc.), brain pathology (tumor, stroke, Parkinson's disease, etc.), or epilepsy * Presence of claustrophobia, acrophobia, photophobia, severe hearing loss, and/or severe visual deficit * Contraindication to IVR (migraines, photosensitive epilepsy, vertigo)
Where it's running
-
Geneva University Hospitals
Geneva, Canton of Geneva, Switzerland Recruiting
Study contacts
- Principal investigator: Lisa Hentsch, Dr med — University Hospital, Geneva
- Study coordinator: Lisa Hentsch, Dr med
- Email: lisa.hentsch@hug.ch
- Phone: +41795531093
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Somatic health screening for adults in psychiatric outpatient care
This program tries adding regular physical-health screening into psychiatric outpatient care to see if it helps detect and manage heart disease, lung disease, diabetes, and other conditions in adults with psychotic or affective disorders.
-
Managing multiple medications in older adults with chronic diseases
This project will see if taking many different medicines changes the health outlook of people aged 65 and older who have chronic conditions.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.